Haleos Labs Limited (HALEOSLABS) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Haleos Labs Limited stock ₹597, price ₹1,590, that is 62.5% below the price, quality 43 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Haleos Labs Limited
HALEOSLABS · NSEFar too expensive (fair value 63% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ₹484.22 – ₹1,744 · fair‑value band ₹565.34 – ₹706.25 · the ₹1,590 price screens above the ₹596.84 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Haleos Labs is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.
Show moreShow less
The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products.
It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.
Stock analysis
Haleos Labs Limited (HALEOSLABS) currently trades at ₹1,590, while our model-based Fair Value estimate is ₹596.84, 63% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹1,117 per share, and 1 of the 14 models we run sit above the ₹1,590 price.
Bear case: the Asset-Based group reads lowest at ₹473.19, and 13 of the 14 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹565.34 (bear) to ₹706.25 (bull), the price of ₹1,590 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Haleos Labs Limited reported revenue of ₹3.3B in FY2026 versus ₹3.5B in FY2022, a compound −1.0%/yr. Reported net income was ₹173M in FY2026, compounding −9.1%/yr from FY2022.
Key figures
Market cap ₹4.8B (≈ $51.0M) Micro · P/E ratio 30.4 · P/S ratio 1.48 · EPS (TTM) ₹52.27 · Dividend yield 0.1% · Net margin 4.9% · Return on equity 8.1% · Return on assets (EBIT) 6.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (low confidence).
What moves the price
The share trades about 6% below its 52-week high and 41% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at −63%, HALEOSLABS screens richer than that median.
Fair Value models
All 14 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare Haleos Labs Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 850 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/B ratio by industry
- Net margin by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Healthcare
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $955.47 | $1,275 | +33% | vs HALEOSLABS |
| Genmab A/S GMAB | kr 3,448 | kr 3,917 | +14% | vs HALEOSLABS |
| Vertex Pharmaceuticals Incorporated VRTX | $538.60 | $592.46 | +10% | vs HALEOSLABS |
| Samsung Biologics Co 207940 | 1,411,000 KRW | 1,552,100 KRW | +10% | vs HALEOSLABS |
| argenx SE ARGX | $960.04 | $908.40 | −5% | vs HALEOSLABS |
| CSL Limited CSL | A$202.92 | A$185.51 | −9% | vs HALEOSLABS |
| Moderna, Inc MRNA | $223.37 | $139.99 | −37% | vs HALEOSLABS |
| Roivant Sciences Ltd ROIV | $39.53 | $19.47 | −51% | vs HALEOSLABS |
| Celltrion, Inc 068270 | 214,000 KRW | 74,945 KRW | −65% | vs HALEOSLABS |
| Royalty Pharma plc RPRX | $69.31 | $19.01 | −73% | vs HALEOSLABS |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Haleos Labs Limited (HALEOSLABS) overvalued or undervalued?
What is the fair value of HALEOSLABS?
What is the quality score of HALEOSLABS?
What is the price target for Haleos Labs Limited (HALEOSLABS)?
What is the Haleos Labs Limited stock forecast for 2026?
What is the revenue of Haleos Labs Limited (HALEOSLABS)?
Does Haleos Labs Limited pay a dividend?
How much is the dividend of Haleos Labs Limited (HALEOSLABS) and when is the ex-dividend date?
What is the intrinsic value of Haleos Labs Limited (HALEOSLABS)?
Is Haleos Labs Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of HALEOSLABS?
How much is Haleos Labs Limited worth?
What do the bullish and bearish scenarios say about HALEOSLABS?
What is the P/E ratio of HALEOSLABS?
How solid is the balance sheet of Haleos Labs Limited (HALEOSLABS)?
How far is HALEOSLABS from its 52-week high?
Which stocks are comparable to Haleos Labs Limited?
Is Haleos Labs Limited stock attractive at the current price?
How is the fair value of HALEOSLABS calculated?
Is it still worth investing in stocks now?
What is the share price of Haleos Labs Limited (HALEOSLABS)?
What should I pay attention to with Haleos Labs Limited right now?
Key figures of Haleos Labs Limited
How large is the market capitalisation of Haleos Labs Limited (HALEOSLABS)?
What is the P/S ratio of Haleos Labs Limited (HALEOSLABS)?
What are the earnings per share of Haleos Labs Limited (HALEOSLABS)?
What is the dividend yield of Haleos Labs Limited (HALEOSLABS)?
What is the net margin of Haleos Labs Limited (HALEOSLABS)?
What is the return on equity of Haleos Labs Limited (HALEOSLABS)?
What is the EBIT return on assets of Haleos Labs Limited (HALEOSLABS)?
What is the operating margin of Haleos Labs Limited (HALEOSLABS)?
How fast is revenue growing at Haleos Labs Limited (HALEOSLABS)?
How fast are earnings growing at Haleos Labs Limited (HALEOSLABS)?
How much free cash flow does Haleos Labs Limited (HALEOSLABS) generate?
How much net debt does Haleos Labs Limited (HALEOSLABS) carry?
Watch Haleos Labs Limited in the live analysis
One click puts Haleos Labs Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.